Increase of neuronal histamine in obese rats is associated with decreases in body weight and plasma triglycerides

Obesity

Volumn 14, Issue 12, 2006, Pages 2154-2162

  Malmlöf, Kjell ^a   Golozoubova, Valeria ^a   Peschke, Bernd ^a   Wulff, Birgitte S ^a   Refsgaard, Hanne H F ^a   Johansen, Peter B ^a   Cremers, Thomas ^b   Rimvall, Karin ^a  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Blood lipids; Body weight; Energy expenditure; Food intake; Histamine H3 receptor antagonist

Indexed keywords

ANTIHISTAMINIC AGENT; HISTAMINE; HISTAMINE H3 RECEPTOR; NNC 38 1049; NNC 38-1049; PIPERAZINE DERIVATIVE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL; ANTERIOR HYPOTHALAMUS; ARTICLE; BLOOD; BODY WEIGHT; DOSE RESPONSE; DRUG EFFECT; EATING; MALE; METABOLISM; OBESITY; ORAL DRUG ADMINISTRATION; RAT; SPRAGUE DAWLEY RAT; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; HISTAMINE; HISTAMINE ANTAGONISTS; MALE; OBESITY; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, HISTAMINE H3; TRIGLYCERIDES; WEIGHT LOSS;

EID: 33846295602     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2006.252     Document Type: Article

References (46)

1. Kopelman PG. Obesity as a medical problem. Nature. 2000; 404:635-43.
2. Klein S. Outcome success in obesity. Obes Res. 2001;9(Suppl 4):354-8S.
3. Mann JI. Can dietary intervention produce long-term reduction in insulin resistance? Br J Nutr. 2000;83(Suppl 1):S169-72.
4. Curioni CC, Lourenco PM. Long-term weight loss after diet and exercise: a systematic review. Int J Obes. 2005;29:1168-74.
5. Katz DL. Competing dietary claims for weight loss: finding the forest through truculent trees. Annu Rev Public Health. 2005;26:61-88.
6. Wing RR, Venditti E, Jakicic JM, Polley BA, Lang W. Lifestyle intervention in overweight individuals with a family history of diabetes. Diabetes Care. 1998;3:350-9.
7. Finer N. Pharmacotherapy of obesity. Best Pract Res Clin Endocrinol Metab. 2002;4:717-42.
8. Small CJ, Bloom SR. Gut hormones and the control of appetite. Trends Endocrinol Metab. 2004;6:259-63.
9. Woods SC. Gastrointestinal satiety signals I. An overview of gastrointestinal signals that influence food intake. Am J Physiol Gastrointest Liver Physiol. 2004;286:G7-13.
10. Elmquist JK, Flier JS. Neuroscience. The fat-brain axis enters a new dimension. Science. 2004;304:63-4.
11. Mercer LP, Kelley DS, Humphries LL, Dunn JD. Manipulation of central nervous system histamine or histaminergic receptors (H1) affects food intake in rats. J Nutr. 1994;7: 1029-36.
12. Haq AU, Bundrant HM, Mercer LP. Food intake is inversely correlated with central nervous system histamine receptor (H1) concentrations in male Sprague-Dawley rats fed normal, low protein, low energy or poor quality protein diets. J Nutr. 1996;126:3083-9.
13. Ookuma K, Yoshimatsu H, Sakata T, Fujimoto K, Fukagawa F. Hypothalamic sites of neuronal histamine action on food intake by rats. Brain Res. 1989;2:268-75.
14. 3) of histamine receptor. Nature. 1983;302:832-7.
15. 3 receptor. Mol Pharmacol. 1999;6:1101-7.
16. Lovenberg TW, Pyati J, Chang H, Wilson SJ, Erlander MG. Cloning of rat histamine H(3) receptor reveals distinct species pharmacological profiles. J Pharmacol Exp Ther. 2000;293:771-8.
17. Malmlof K, Zaragoza F, Golozoubova V, et al. Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight. Int J Obes (Lond). 2005;29:1402-12.
18. 3 receptor antagonist. Eur J Pharmacol. 2004;487:183-97.
19. Zaragoza F, Stephensen H, Knudsen SM, Pridal L, Wulff BS, Rimvall K. 1-Alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists. J Med Chem. 2004;47:2833-8.
20. 3 antagonists. Bioorg Med Chem. 2004;12:2603-16.
21. 3 receptors. Eur J Pharmacol. 2002;453:33-41.
22. Malmlof K, Johansen T. Growth hormone-mediated break-down of body fat: insulin and leptin responses to GH are modulated by diet composition and caloric intake in old rats. Hormone Met Res. 2003;35:236-42.
23. Johansen T, Deckert M, Mandrup-Poulsen T, Malmlof K. The role of growth hormone and glucocorticoid in glucose handling in vivo. J Endocrinol. 1999;162:87-93.
24. Williams G, Bing C, Cai XJ, Harrold JA, King PJ, Liu XH. The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol Behav. 2001;74: 683-701.
25. 3 receptor antagonists/ inverse agonists. Expert Opin Investig Drugs. 2005;14:223-41.
26. 3R activation by thioperamide does not affect energy balance. Pharmacol Biochem Behav. 2004;78:275-83.
27. Fontana L, Meyer TE, Klein S, Holloszy JO. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci USA. 2004; 101:6659-63.
28. Harder H, Dinesen B, Astrup A. The effect of a rapid weight loss on lipid profile and glycemic control in obese type 2 diabetic patients. Int J Obes. 2004;28:180-2.
29. Vaisman N, Sklan D, Dayan Y. Effect of moderate semistarvation on plasma lipids. Int J Obes. 1990;14:989-96.
30. Davignon J, Cohn JS. Triglycerides: a risk factor for coronary heart disease. Atherosclerosis. 1996;124(suppl):S57-64.
31. Krauss RM. Triglycerides and atherogenic lipoproteins: rationale for lipid management. Am J Med. 1998;1A:58-62S.
32. Frayn KN. Adipose tissue and the insulin resistance syndrome. Proc Nutr Soc. 2001;60:375-80.
33. Kelley DE, Goodpaster BH, Storlien L. Muscle triglyceride and insulin resistance. Annu Rev Nutr. 2002;22:325-46.
34. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 2002;51:7-18.
35. Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation. 2002;106:286-8.
36. Teusink B, Voshol PJ, Dahlmans VE, et al. Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake. Diabetes. 2003;3:614-20.
37. Griffiths AJ, Humphreys SM, Clark ML, Fielding BA, Frayn KN. Immediate metabolic availability of dietary fat in combination with carbohydrate. Am J Clin Nutr. 1994;59:53-9.
38. Tancredi RG, Dagenais GR, Zierler KL. Free fatty acid metabolism in the forearm at rest: muscle uptake and adipose tissue release of free fatty acids. Johns Hopkins Med J. 1976; 138:167-79.
39. Corton JC, Apte U, Anderson SP, et al. Mimetics of caloric restriction include agonists of lipid-activated nuclear receptors. J Biol Chem. 2004;279:46204-12.
40. Eaton S. Control of mitochondrial beta-oxidation flux. Prog Lipid Res. 2002;41:197-239.
41. Goodpaster BH, Kelley DE, Wing RR, Meier A, Thaete FL. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes. 1999;48:839-47.
42. Mustonen A-M, Pyykönen T, Paakkonen T, et al. Adaptations to fasting in the American mink (Mustela vison): carbohydrate and lipid metabolism. Comp Biochem Physiol A Mol Integr Physiol. 2005;140:195-202.
43. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1: 785-9.
44. Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest. 2002: 32(Suppl 3):14-23.
45. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest. 1994;93:2438-46.
46. Tsuda K, Yoshimatsu H, Niijima A, Chiba S, Okeda T, Sakata T. Hypothalamic histamine neurons activate lipolysis in rat adipose tissue. Exp Biol Med. 2002;227:208-13.